Penumbra (PEN) shares were up more than 11% in recent Wednesday trading following its better-than-expected Q2 results and an increase in its revenue guidance in the previous day.
"PEN delivered a Q2 beat, and raised 2025 guidance based on
strong peripheral vascular growth and above market growth in stroke," RBC analysts said in a note.
"We believe business momentum at PEN is robust," they added.
RBC reaffirmed its outperform rating while lowering its price target to $325 from $330.
Separately, UBS raised its price target to $335 from $330, and Truist raised its price target to $310 from $300.
More than 736,000 shares were traded, compared with an average volume of about 486,000.
Price: 253.12, Change: +25.97, Percent Change: +11.43